blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0314569

EP0314569 - Recombinant fowlpox virus, expression vectors for heterologous proteins, and vaccines for fowl derived from this virus [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.01.1995
Database last updated on 03.06.2024
Most recent event   Tooltip05.01.1995No opposition filed within time limitpublished on 22.02.1995 [1995/08]
Applicant(s)For all designated states
TRANSGENE S.A.
11, rue de Molsheim
67000 Strasbourg / FR
[N/P]
Former [1993/47]For all designated states
TRANSGENE S.A.
11, rue de Molsheim
F-67000 Strasbourg / FR
Former [1989/18]For all designated states
TRANSGENE S.A.
16, rue Henri-Régnault
F-92411 Courbevoie Cédex / FR
Inventor(s)01 / Drillien, Robert
10, Bd Paul Déroulède
F-67100 Strasbourg / FR
02 / Spehner, Danièle
29, rue de la Chênaie
F-67200 Eckbolsheim / FR
[1989/18]
Representative(s)Warcoin, Jacques, et al
Cabinet Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[N/P]
Former [1989/18]Warcoin, Jacques, et al
Cabinet Régimbeau, 26, avenue Kléber
F-75116 Paris / FR
Application number, filing date88402695.626.10.1988
[1989/18]
Priority number, dateFR1987001500129.10.1987         Original published format: FR 8715001
FR1988000822620.06.1988         Original published format: FR 8808226
[1989/18]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP0314569
Date:03.05.1989
Language:FR
[1989/18]
Type: B1 Patent specification 
No.:EP0314569
Date:02.03.1994
Language:FR
[1994/09]
Search report(s)(Supplementary) European search report - dispatched on:EP16.02.1989
ClassificationIPC:C12N15/86, A61K39/275, A61K39/155, A61K39/165, A61K39/175, A61K39/295
[1994/09]
CPC:
C12N15/86 (EP,US); A61P31/12 (EP); C07K14/005 (EP,US);
A61K39/00 (EP,US); C12N2710/24022 (EP,US); C12N2710/24043 (EP,US);
C12N2760/18122 (EP,US); C12N2760/18422 (EP,US); C12N2760/18622 (EP,US);
C12N2770/20022 (EP,US) (-)
Former IPC [1989/18]C12N15/00, A61K39/275, A61K39/155, A61K39/165, A61K39/175, A61K39/295
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1989/18]
TitleGerman:Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine[1989/18]
English:Recombinant fowlpox virus, expression vectors for heterologous proteins, and vaccines for fowl derived from this virus[1989/18]
French:Virus du fowlpox recombinant, vecteurs d'expression de protéines héterologues et vaccins pour la volaille dérivés de ce virus[1989/18]
Examination procedure19.06.1989Request for accelerated examination filed
12.10.1989Examination requested  [1989/49]
05.04.1990Despatch of a communication from the examining division (Time limit: M04)
05.04.1990Decision about request for accelerated examination - accepted: Yes
06.08.1990Reply to a communication from the examining division
29.04.1991Despatch of a communication from the examining division (Time limit: M06)
13.12.1991Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
10.02.1992Reply to a communication from the examining division
23.10.1992Despatch of communication of intention to grant (Approval: No)
15.06.1993Despatch of communication of intention to grant (Approval: later approval)
23.07.1993Communication of intention to grant the patent
26.10.1993Fee for grant paid
26.10.1993Fee for publishing/printing paid
Opposition(s)03.12.1994No opposition filed within time limit [1995/08]
Request for further processing for:10.02.1992Request for further processing filed
10.02.1992Full payment received (date of receipt of payment)
Request granted
19.03.1992Decision despatched
Fees paidRenewal fee
17.09.1990Renewal fee patent year 03
23.09.1991Renewal fee patent year 04
21.09.1992Renewal fee patent year 05
27.09.1993Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US3429965  (GELENCZEI EMIL F, et al);
 [X]WO8600528  (GENEX CORP [US]);
 [X]WO8605806  (NAT RES DEV [GB]);
 [X]EP0227414  (NAT RES DEV [GB]);
 [YP]EP0257994  (TOA NENRYO KOGYO KK [JP]);
 [XP]WO8802022  (COMMW SCIENT IND RES ORG [AU], et al);
 [XP]EP0284416  (NIPPON ZEON CO [JP])
 [X]  - J. GEN VIROL, vol. 67, 1986, pages 1591-1600, GB; D.B. BOYLE et al.: "Identification and cloning of the fowlpox virus thymidine kinase gene using vaccinia virus"
 [YD]  - VIROLOGY, vol. 160, no. 1, 1987, pages 203-209; R. DRILLIEN et al.: "Similar genetic organization between a region of fowlpox virus DNA and the vaccinia virus Hindlll J fragment despite divergent location of the thymidine kinase gene"
 [Y]  - VACCINE, vol. 5, no. 1, mars 1987, pages 65-70, Butterworth & Co. (Publishers) Ltd, Guildford, Surrey, GB; M. MORITA et al.: "Recombinant vaccinia virus LC16mO or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain"
 [Y]  - NATURE, vol. 326, no. 6116, 30 avril-6 mai 1987, pages 878-880, Londres, GB; R. LATHE et al.: "Tumour prevention and rejection with recombinant vaccinia"
 [Y]  - CHEMICAL ABSTRACTS, vol. 103, no. 1, juillet 1985, pages 152-153, résumé no. 1555s, Columbus, Ohio, US; S.E.H. RUSSELL et al.: "Molecular cloning of measles and canine distemper viruses", & BIOCHEM. SOC. TRANS. 1985, 13(2), 478-9
 [A]  - GENE, vol. 47, no. 2/3, 1986, pages 193-199, Elsevier Science Publishers B.V., Amsterdam, NL; D. PANICALI et al.: "Vaccinia virus vectors utilizing the beta-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression"
 [XP]  - BIOLOGICAL ABSTRACTS, vol. 10, no. 4, 1988, pages 343-356, Philadelphia, US; D.B. BOYLE et al.: "Construction of recombinant fowlpox viruses as vectors for poultry vaccines"
 [YP]  - PROC. NATL. ACAD. SCI, vol. 85, février 1988, pages 1252-1256, US; R. DRILLIEN et al.: "Protection of mice from fatal measles encephalitis by vaccination with vaccina virus recombinants encoding either the hemagglutinin or the fusion protein"
Examination   - VACCINE, vol. 5, no. 1, mars 1987, pages 65-70, Butterworth & Co. (Publishers) Ltd., Guildford, Surrey (GB); M. MORITA et al., pp. 65-70#
    - NATURE, vol. 326, no. 6116, 30 avril-06 mai 1987, Londres (GB); R. LATHE et al., pp. 878-880#
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.